Prism Medico & Pharmacy Current Share Price | Prism Medico & Pharmacy Stock Screener
PRISMMEDI
NBFC
Prism Medico & Pharmacy Current Stock Price Today
Live Share Price BSE
₹28.11
▲
0.72 (2.63%)
As of August 18, 2026, the live Prism Medico & Pharmacy share price (BSE: PRISMMEDI) is ₹28.11, up 2.63% from the previous close, with shares trading between ₹27.75 and ₹28.15 in today's trading session, and a 52-week range of ₹16.03–₹33.90.
Analyse PRISMMEDI share price charts and track historical price performance.
Use the Prism Medico & Pharmacy stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Prism Medico & Pharmacy Market Cap
₹37.03 Cr.
PRISMMEDI P/E Ratio (TTM)
-92.03
Prism Medico & Pharmacy P/B Ratio
1.58
EPS (TTM)
₹0.07
Dividend Yield
-
Debt to Equity
0.17
PRISMMEDI 52 Week High
₹33.90
Prism Medico & Pharmacy 52 Week Low
₹16.03
Operating Margin
-5.00%
Profit Margin
-5.88%
PRISMMEDI Revenue (TTM)
₹17.00
EBITDA
₹-1.00
Net Income
₹-1.00
Total Assets
₹21.00
Total Equity
₹13.00
Prism Medico & Pharmacy Current Share Price Chart
Track the current Prism Medico & Pharmacy share price and stock price with an interactive chart. Analyse PRISMMEDI price trends, trading volume, historical performance, and volatility across different timeframes — the complete Prism Medico & Pharmacy stock quote in one place.
Prism Medico & Pharmacy Company Profile - Fundamental Screener
Screen Prism Medico & Pharmacy company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for PRISMMEDI shares.
Sector
Financial Services
Industry
NBFC
Sub-Sector
NBFC
Segment
E
ISIN
INE730E01016
Prism Medico & Pharmacy Balance Sheet Screener
Screen PRISMMEDI balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2019 | 2018 | 2017 |
|---|---|---|---|
| Assets | |||
| Total Assets | 21 | 16 | 17 |
| Current Assets | 11 | 4 | 7 |
| Fixed Assets | 9 | 9 | 10 |
| Liabilities | |||
| Total Liabilities | 0 | 0 | 0 |
| Current Liabilities | 0 | 0 | 3 |
| Non-Current Liabilities | 0 | 0 | 0 |
| Shareholders' Equity | |||
| Total Equity | 13 | 13 | 13 |
| Share Capital | 6 | 6 | 6 |
| Reserves & Surplus | 7 | 7 | 7 |
Prism Medico & Pharmacy Income Statement Screener - Profit & Revenue Analysis
Screen Prism Medico & Pharmacy income statement and profit fundamentals.
Analyze PRISMMEDI quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Prism Medico & Pharmacy share price evaluation.
| Item | 2019-Mar | 2019-Jun | 2019-Sept | 2019-Dec | 2018-Mar | 2018-Jun | 2018-Sept | 2018-Dec | 2017-Mar | 2017-Jun | 2017-Sept | 2017-Dec | 2016-Mar | 2016-Jun |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 17 | 9 | 7 | 10 | 0 | 6 | 15 | 17 | 3 | 12 | 6 | 5 | 0 | 0 |
| Expenses | 17 | 9 | 6 | 10 | 1 | 5 | 15 | 17 | 2 | 11 | 6 | 5 | 0 | 0 |
| EBITDA | -1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 |
| Operating Profit % | -5.00% | 2.00% | 3.00% | 0.00% | -50.00% | 7.00% | 2.00% | 1.00% | 26.00% | 7.00% | 1.00% | 1.00% | 0.00% | 0.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 |
| EPS | -1.21 | 0.21 | 0.15 | -0.07 | -0.70 | 0.62 | 0.46 | 0.24 | 0.90 | 1.12 | -0.23 | -0.19 | 0.00 | -0.53 |
Prism Medico & Pharmacy Cash Flow Screener - Liquidity Fundamentals
Screen PRISMMEDI cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2019-March | 2018-March | 2017-March |
|---|---|---|---|
| Operating Activities | 0 | 4 | 0 |
| Investing Activities | 0 | -3 | 0 |
| Financing Activities | -1 | -2 | 0 |
| Net Cash Flow | -1 | -1 | 0 |
Prism Medico & Pharmacy Shareholding Pattern Screener
See Prism Medico & Pharmacy shareholding pattern with promoter, FII, and DII holdings.
Check Prism Medico & Pharmacy promoter holding and ownership changes for PRISMMEDI on TickJournal.
| Item | 2026-Mar | 2026-May | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 25.49% | 30.20% | 29.98% | 25.00% | 25.00% | 25.00% | 25.00% | 25.00% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 66.00% | 66.00% | 65.94% | 66.07% | 65.26% | 65.26% | 65.63% | 67.23% |
| Other Holding | 8.51% | 3.80% | 4.08% | 8.93% | 9.74% | 9.74% | 9.37% | 7.77% |
| Shareholder Count | 4,295 | 4,300 | 4,177 | 4,302 | 4,306 | 4,315 | 4,306 | 3,792 |
Prism Medico & Pharmacy Share Dividend Screener - Share Yield Analysis
Check Prism Medico & Pharmacy dividend history with payout and yield data.
View Prism Medico & Pharmacy dividend details including ex-dates and amounts for PRISMMEDI stock.
Prism Medico & Pharmacy Stock Index Membership
See which indices include Prism Medico & Pharmacy stock.
Check PRISMMEDI index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Prism Medico & Pharmacy Market Events Screener - Corporate Actions
Get Prism Medico & Pharmacy corporate actions including splits, bonuses, and buybacks.
Check Prism Medico & Pharmacy stock events that may affect PRISMMEDI share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-08-12 | 2026-08-12 | Quarterly Result Announcement | NA | -8.63% |
| 2026-05-28 | 2026-05-28 | Quarterly Result Announcement | NA | -4.95% |
| 2026-03-20 | 2026-03-20 | Extraordinary General Meeting | NA | 13.11% |
| 2026-02-13 | 2026-02-13 | Quarterly Result Announcement | NA | -7.32% |
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | 1.89% |
| 2025-09-30 | 2025-09-30 | Annual General Meeting | NA | 20.06% |
| 2025-08-14 | 2025-08-14 | Quarterly Result Announcement | NA | 0.65% |
| 2025-05-28 | 2025-05-28 | Quarterly Result Announcement | NA | 13.42% |
| 2025-02-14 | 2025-02-14 | Quarterly Result Announcement | NA | -3.47% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | 2.04% |
| 2024-09-30 | 2024-09-30 | Annual General Meeting | NA | -14.25% |
| 2018-05-30 | 2018-05-30 | Change Of Name | NA | 0.00% |
Prism Medico & Pharmacy Competitors Screener - Peer Comparison
Screen PRISMMEDI competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Bajaj Finance | 676,761 | 32.89 | 81,990 | 19.09% | 19,332 | 53.74 |
| Shriram Finance | 263,988 | 23.45 | 48,193 | 15.13% | 10,004 | 60.31 |
| Jio Financial Services | 164,451 | 81.47 | 3,543 | 70.41% | 1,561 | 50.13 |
| Cholamandalam Investment | 161,495 | 28.46 | 31,539 | 20.59% | 5,229 | 57.66 |
| Muthoot Finance | 114,097 | 10.06 | 31,263 | 54.27% | 10,607 | 36.97 |
| SBI Cards | 60,237 | 26.90 | 20,708 | 11.11% | 2,167 | 45.07 |
| M&M Financial Services | 54,223 | 16.91 | 21,087 | 13.79% | 2,861 | 57.73 |
| Sundaram Finance | 49,669 | 22.76 | 9,873 | 15.30% | 2,005 | 45.63 |
| Authum Inv & Infr | 47,973 | 23.48 | 2,609 | -43.44% | 2,101 | 53.37 |
| Poonawalla Fincorp | 43,839 | 56.18 | 6,796 | 60.93% | 542 | 61.69 |
Prism Medico & Pharmacy Company Announcements - News Screener
Screen PRISMMEDI latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-08-15 | Board Meeting Outcome for Outcome Of The Board Meeting - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. | - |
| 2026-08-05 | Board Meeting Intimation for Regulation 29(1) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. | - |
| 2026-07-30 | Undertaking Of Functional Website. | - |
| 2026-07-21 | Investor Complaints As Per Regulation 13(3) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015. | - |
| 2026-07-13 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-07-06 | Compliance-57 (5) : intimation after the end of quarter | - |
| 2026-06-30 | Compliance-57 (4) : Prior intimation to the beginning of the quarter | - |
| 2026-06-30 | Closure of Trading Window | - |
| 2026-05-28 | Board Meeting Outcome for Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. | - |
| 2026-05-23 | Board Meeting Intimation for Regulation 29(1) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. | - |
| 2026-05-11 | Board Meeting Outcome for Outcome Of The Board Meeting - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. | - |
| 2026-05-05 | Announcement under Regulation 30 (LODR)-Allotment | - |
| 2026-05-05 | Board Meeting Outcome for Outcome Of Board Meeting For Allotment Of Securities | - |
| 2026-04-29 | Confirmation Regarding Non-Applicability Of Large Corporate Entity Framework. | - |
| 2026-04-21 | Investor Complaints As Per Regulation 13(3) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015. | - |
| 2026-04-13 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-04-07 | Compliance-57 (5) : intimation after the end of quarter | - |
| 2026-04-07 | Disclosures Under Regulation 31(4) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations 2011 For The Financial Year Ended 31St March 2026. | - |
| 2026-04-06 | Compliance-57 (5) : intimation after the end of quarter | - |
| 2026-03-30 | Intimation Under Regulation 57(4) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. | - |